Manufacturer
Janssen (Johnson & Johnson) NDC Codes
Finished products listed with the FDA under labeler names that contain “Janssen”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Intelenceetravirine | Etravirine 25 mg/1 | TabletOral | Janssen Products LP | 59676-572 |
| Invegapaliperidone | Paliperidone 3 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-550 |
| Invegapaliperidone | Paliperidone 6 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-551 |
| Invegapaliperidone | Paliperidone 9 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-552 |
| Invegapaliperidone | Paliperidone 1.5 mg/1 | Tablet, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-554 |
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1092 mg/3.5mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-611 |
| Invega Hafyerapaliperidone palmitate | Paliperidone palmitate 1560 mg/5mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-612 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 39 mg/.25mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-560 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 78 mg/.5mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-561 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 117 mg/.75mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-562 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 156 mg/mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-563 |
| Invega Sustennapaliperidone palmitate | Paliperidone palmitate 234 mg/1.5mL | InjectionIntramuscular | Janssen Pharmaceuticals, Inc. | 50458-564 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 273 mg/.88mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-606 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 410 mg/1.32mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-607 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 546 mg/1.75mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-608 |
| Invega Trinzapaliperidone palmitate | Paliperidone palmitate 819 mg/2.63mL | Injection, Suspension, Extended releaseIntramuscular | Janssen Pharmaceuticals, Inc | 50458-609 |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-540 |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-541 |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-542 |
| Invokametcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-543 |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-940 |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-941 |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-942 |
| Invokamet XRcanagliflozin and metformin hydrochloride | Canagliflozin 150 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | Janssen Pharmaceuticals, Inc. | 50458-943 |
| Invokanacanagliflozin | Canagliflozin 100 mg/1 | Tablet, Film coatedOral | Janssen Pharmaceuticals, Inc. | 50458-140 |